LEPU BIO Posts Static Share Capital in June 2026, Confirms Sufficient Public Float

Bulletin Express07-06

Lepu Biopharma Co., Ltd. (LEPU BIO) filed its Monthly Return to Hong Kong Exchanges for the period ended 30 June 2026, showing no movement in either authorised or issued share capital.

The authorised and registered capital closed the month unchanged at 1.80 billion ordinary H shares with a par value of RMB 1 each, amounting to RMB 1.80 billion in total.

Issued share capital also remained steady at 1.80 billion shares. The company held no treasury shares during the month, leaving total issued shares identical to the prior month.

LEPU BIO confirmed that its public float exceeded the Main Board’s minimum 25 % threshold, thereby remaining in full compliance with Hong Kong Listing Rule 13.32D.

The filing recorded no activity in share options, warrants, convertible securities, other share-issuance agreements, or Hong Kong Depositary Receipts.

The return was submitted on 6 July 2026 and signed by Joint Company Secretary Ms. Li Yunyi, affirming compliance with all applicable listing and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1170700150?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-06 18:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170700150","market":"hk","top_or_hot":-1,"title":"LEPU BIO Posts Static Share Capital in June 2026, Confirms Sufficient Public Float","media":"Bulletin Express","content":"<p>Lepu Biopharma Co., Ltd. (LEPU BIO) filed its Monthly Return to Hong Kong Exchanges for the period ended 30 June 2026, showing no movement in either authorised or issued share capital.</p>\n<p>The authorised and registered capital closed the month unchanged at 1.80 billion ordinary H shares with a par value of RMB 1 each, amounting to RMB 1.80 billion in total.</p>\n<p>Issued share capital also remained steady at 1.80 billion shares. The company held no treasury shares during the month, leaving total issued shares identical to the prior month.</p>\n<p>LEPU BIO confirmed that its public float exceeded the Main Board’s minimum 25 % threshold, thereby remaining in full compliance with Hong Kong Listing Rule 13.32D.</p>\n<p>The filing recorded no activity in share options, warrants, convertible securities, other share-issuance agreements, or Hong Kong Depositary Receipts.</p>\n<p>The return was submitted on 6 July 2026 and signed by Joint Company Secretary Ms. Li Yunyi, affirming compliance with all applicable listing and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LEPU BIO Posts Static Share Capital in June 2026, Confirms Sufficient Public Float</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLEPU BIO Posts Static Share Capital in June 2026, Confirms Sufficient Public Float\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-06 18:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Lepu Biopharma Co., Ltd. (LEPU BIO) filed its Monthly Return to Hong Kong Exchanges for the period ended 30 June 2026, showing no movement in either authorised or issued share capital.</p>\n<p>The authorised and registered capital closed the month unchanged at 1.80 billion ordinary H shares with a par value of RMB 1 each, amounting to RMB 1.80 billion in total.</p>\n<p>Issued share capital also remained steady at 1.80 billion shares. The company held no treasury shares during the month, leaving total issued shares identical to the prior month.</p>\n<p>LEPU BIO confirmed that its public float exceeded the Main Board’s minimum 25 % threshold, thereby remaining in full compliance with Hong Kong Listing Rule 13.32D.</p>\n<p>The filing recorded no activity in share options, warrants, convertible securities, other share-issuance agreements, or Hong Kong Depositary Receipts.</p>\n<p>The return was submitted on 6 July 2026 and signed by Joint Company Secretary Ms. Li Yunyi, affirming compliance with all applicable listing and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02157","symbol_name":"乐普生物","start_time":0,"source_url":"","article_id":"1170700150","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170700150","pubTimestamp":1783333786,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Lepu Biopharma Co., Ltd. (LEPU BIO) filed its Monthly Return to Hong Kong Exchanges for the period ended 30 June 2026, showing no movement in either authorised or issued share capital. The authorised...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02157":"乐普生物"},"translate_title":"乐普生物2026年6月公布静态股本，确认公众持股量充足","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02157":1},"content_text":"Lepu Biopharma Co., Ltd. (LEPU BIO) filed its Monthly Return to Hong Kong Exchanges for the period ended 30 June 2026, showing no movement in either authorised or issued share capital.\nThe authorised and registered capital closed the month unchanged at 1.80 billion ordinary H shares with a par value of RMB 1 each, amounting to RMB 1.80 billion in total.\nIssued share capital also remained steady at 1.80 billion shares. The company held no treasury shares during the month, leaving total issued shares identical to the prior month.\nLEPU BIO confirmed that its public float exceeded the Main Board’s minimum 25 % threshold, thereby remaining in full compliance with Hong Kong Listing Rule 13.32D.\nThe filing recorded no activity in share options, warrants, convertible securities, other share-issuance agreements, or Hong Kong Depositary Receipts.\nThe return was submitted on 6 July 2026 and signed by Joint Company Secretary Ms. Li Yunyi, affirming compliance with all applicable listing and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1170700150","isCrawlerRequest":true}